CIAM
DYN icon

Caitong International Asset Management’s Dyne Therapeutics DYN Stock Holding History

Caitong International Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Buy
+10,405
New +$179K 0.03% 402
2025
Q3 		– Sell
-1,308
Closed -$12.5K – 2090
2025
Q2 		$12.5K Sell
1,308
-1,784
-58% -$19.6K 0.01% 646
2025
Q1 		$32.3K Buy
3,092
+2,446
+379% +$35K 0.02% 629
2024
Q4 		$15.2K Buy
+646
New +$19.1K 0.01% 869

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Caitong International Asset Management's DYN Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Dyne Therapeutics (DYN) in Q1 2026: 10,405 shares worth $189K. The stake represents 0.03% of the portfolio and ranks #402 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in DYN as recently as Q2 2025.

Caitong International Asset Management first reported a position in DYN in Q4 2024 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Caitong International Asset Management held 10,405 shares of Dyne Therapeutics worth $189K as of Q1 2026.
  • Dyne Therapeutics was a new Caitong International Asset Management position in Q1 2026.
  • Dyne Therapeutics made up 0.03% of Caitong International Asset Management's portfolio in Q1 2026, its #402 holding.
  • Caitong International Asset Management first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.